Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer.

Miyagawa Y, Matsushita Y, Suzuki H, Komatsu M, Yoshimaru T, Kimura R, Yanai A, Honda J, Tangoku A, Sasa M, Miyoshi Y, Katagiri T.

Int J Oncol. 2018 Mar 5. doi: 10.3892/ijo.2018.4301. [Epub ahead of print]

PMID:
29512727
2.

A DDX31/Mutant-p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer.

Daizumoto K, Yoshimaru T, Matsushita Y, Fukawa T, Uehara H, Ono M, Komatsu M, Kanayama HO, Katagiri T.

Cancer Res. 2018 May 1;78(9):2233-2247. doi: 10.1158/0008-5472.CAN-17-2528. Epub 2018 Feb 13.

PMID:
29440146
3.

A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells.

Yoshimaru T, Ono M, Bando Y, Chen YA, Mizuguchi K, Shima H, Komatsu M, Imoto I, Izumi K, Honda J, Miyoshi Y, Sasa M, Katagiri T.

Nat Commun. 2017 May 30;8:15427. doi: 10.1038/ncomms15427.

4.

Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics.

Yoshimaru T, Aihara K, Komatsu M, Matsushita Y, Okazaki Y, Toyokuni S, Honda J, Sasa M, Miyoshi Y, Otaka A, Katagiri T.

Sci Rep. 2017 May 12;7(1):1821. doi: 10.1038/s41598-017-01951-6.

5.

Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin-containing protein inhibitor.

Shikata Y, Yoshimaru T, Komatsu M, Katoh H, Sato R, Kanagaki S, Okazaki Y, Toyokuni S, Tashiro E, Ishikawa S, Katagiri T, Imoto M.

Cancer Sci. 2017 Apr;108(4):785-794. doi: 10.1111/cas.13175. Epub 2017 Apr 20.

6.

BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells.

Kim NH, Yoshimaru T, Chen YA, Matsuo T, Komatsu M, Miyoshi Y, Tanaka E, Sasa M, Mizuguchi K, Katagiri T.

PLoS One. 2015 Jun 8;10(6):e0127707. doi: 10.1371/journal.pone.0127707. eCollection 2015.

7.

Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer.

Yoshimaru T, Komatsu M, Miyoshi Y, Honda J, Sasa M, Katagiri T.

Cancer Sci. 2015 May;106(5):550-8. doi: 10.1111/cas.12654. Epub 2015 Apr 1.

8.

Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions.

Yoshimaru T, Komatsu M, Tashiro E, Imoto M, Osada H, Miyoshi Y, Honda J, Sasa M, Katagiri T.

Sci Rep. 2014 Dec 8;4:7355. doi: 10.1038/srep07355.

9.

Early growth response 4 is involved in cell proliferation of small cell lung cancer through transcriptional activation of its downstream genes.

Matsuo T, Dat le T, Komatsu M, Yoshimaru T, Daizumoto K, Sone S, Nishioka Y, Katagiri T.

PLoS One. 2014 Nov 20;9(11):e113606. doi: 10.1371/journal.pone.0113606. eCollection 2014.

10.

Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (BIG3) is predicted to interact with its partner through an ARM-type α-helical structure.

Chen YA, Murakami Y, Ahmad S, Yoshimaru T, Katagiri T, Mizuguchi K.

BMC Res Notes. 2014 Jul 6;7:435. doi: 10.1186/1756-0500-7-435.

11.

Involvement of B3GALNT2 overexpression in the cell growth of breast cancer.

Matsuo T, Komatsu M, Yoshimaru T, Kiyotani K, Miyoshi Y, Sasa M, Katagiri T.

Int J Oncol. 2014 Feb;44(2):427-34. doi: 10.3892/ijo.2013.2187. Epub 2013 Nov 27.

PMID:
24285400
12.

Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.

Yoshimaru T, Komatsu M, Matsuo T, Chen YA, Murakami Y, Mizuguchi K, Mizohata E, Inoue T, Akiyama M, Yamaguchi R, Imoto S, Miyano S, Miyoshi Y, Sasa M, Nakamura Y, Katagiri T.

Nat Commun. 2013;4:2443. doi: 10.1038/ncomms3443.

13.

Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis.

Komatsu M, Yoshimaru T, Matsuo T, Kiyotani K, Miyoshi Y, Tanahashi T, Rokutan K, Yamaguchi R, Saito A, Imoto S, Miyano S, Nakamura Y, Sasa M, Shimada M, Katagiri T.

Int J Oncol. 2013 Feb;42(2):478-506. doi: 10.3892/ijo.2012.1744. Epub 2012 Dec 18.

PMID:
23254957
14.

Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice.

Dat le T, Matsuo T, Yoshimaru T, Kakiuchi S, Goto H, Hanibuchi M, Kuramoto T, Nishioka Y, Sone S, Katagiri T.

Int J Oncol. 2012 May;40(5):1455-69. doi: 10.3892/ijo.2012.1348. Epub 2012 Jan 27.

PMID:
22294041
15.

FcepsilonRI beta-chain ITAM amplifies PI3K-signaling to ensure synergistic degranulation response via FcepsilonRI and adenosine receptors.

Nunomura S, Gon Y, Yoshimaru T, Kashiwakura J, Kawakami T, Ra C.

Eur J Immunol. 2010 Apr;40(4):1205-17. doi: 10.1002/eji.200939651.

16.

SHP-1 exhibits a pro-apoptotic function in antigen-stimulated mast cells: positive regulation of mitochondrial death pathways and negative regulation of survival signaling pathways.

Inoue T, Suzuki Y, Mizuno K, Nakata K, Yoshimaru T, Ra C.

Mol Immunol. 2009 Dec;47(2-3):222-32. doi: 10.1016/j.molimm.2009.09.033. Epub 2009 Oct 28.

PMID:
19875169
17.

Nitric Oxide positively regulates Ag (I)-induced Ca(2+) influx and mast cell activation: role of a Nitric Oxide Synthase-independent pathway.

Inoue T, Suzuki Y, Yoshimaru T, Ra C.

J Leukoc Biol. 2009 Dec;86(6):1365-75. doi: 10.1189/jlb.0609387. Epub 2009 Aug 25.

PMID:
19706839
18.

Discrete generations of intracellular hydrogen peroxide and superoxide in antigen-stimulated mast cells: reciprocal regulation of store-operated Ca2+ channel activity.

Suzuki Y, Yoshimaru T, Inoue T, Ra C.

Mol Immunol. 2009 Jul;46(11-12):2200-9. doi: 10.1016/j.molimm.2009.04.013. Epub 2009 May 20.

PMID:
19467708
19.

Ca v 1.2 L-type Ca2+ channel protects mast cells against activation-induced cell death by preventing mitochondrial integrity disruption.

Suzuki Y, Yoshimaru T, Inoue T, Ra C.

Mol Immunol. 2009 Jul;46(11-12):2370-80. doi: 10.1016/j.molimm.2009.03.017. Epub 2009 May 17.

PMID:
19447492
20.

Ca2+-dependent mast cell death induced by Ag (I) via cardiolipin oxidation and ATP depletion.

Inoue T, Suzuki Y, Yoshimaru T, Ra C.

J Leukoc Biol. 2009 Jul;86(1):167-79. doi: 10.1189/jlb.1108691. Epub 2009 Apr 28.

PMID:
19401388
21.

Aspirin and salicylates modulate IgE-mediated leukotriene secretion in mast cells through a dihydropyridine receptor-mediated Ca(2+) influx.

Togo K, Suzuki Y, Yoshimaru T, Inoue T, Terui T, Ochiai T, Ra C.

Clin Immunol. 2009 Apr;131(1):145-56. doi: 10.1016/j.clim.2008.09.008. Epub 2009 Jan 14.

PMID:
19144570
22.

L-type Ca2+ channels in mast cells: activation by membrane depolarization and distinct roles in regulating mediator release from store-operated Ca2+ channels.

Yoshimaru T, Suzuki Y, Inoue T, Ra C.

Mol Immunol. 2009 Apr;46(7):1267-77. doi: 10.1016/j.molimm.2008.11.011. Epub 2009 Jan 6.

PMID:
19128833
23.

Positive and negative regulation of high affinity IgE receptor signaling by Src homology region 2 domain-containing phosphatase 1.

Nakata K, Yoshimaru T, Suzuki Y, Inoue T, Ra C, Yakura H, Mizuno K.

J Immunol. 2008 Oct 15;181(8):5414-24.

24.

Extracellular superoxide released from mitochondria mediates mast cell death by advanced glycation end products.

Yoshimaru T, Suzuki Y, Inoue T, Nishida S, Ra C.

Biochim Biophys Acta. 2008 Dec;1783(12):2332-43. doi: 10.1016/j.bbamcr.2008.08.010. Epub 2008 Sep 6.

25.

Functionality of the IgA Fc receptor (FcalphaR, CD89) is down-regulated by extensive engagement of FcepsilonRI.

Matsui T, Nunomura S, Shimokawa T, Yoshimaru T, Ra C.

Clin Immunol. 2008 Oct;129(1):155-62. doi: 10.1016/j.clim.2008.07.003. Epub 2008 Aug 12.

PMID:
18700185
26.

Na-Tosyl-Phe chloromethyl ketone prevents granule movement and mast cell synergistic degranulation elicited by costimulation of antigen and adenosine.

Nunomura S, Yoshimaru T, Ra C.

Life Sci. 2008 Aug 15;83(7-8):242-9. doi: 10.1016/j.lfs.2008.06.015. Epub 2008 Jun 27.

PMID:
18634805
27.

Galectin-3 but not galectin-1 induces mast cell death by oxidative stress and mitochondrial permeability transition.

Suzuki Y, Inoue T, Yoshimaru T, Ra C.

Biochim Biophys Acta. 2008 May;1783(5):924-34. doi: 10.1016/j.bbamcr.2008.01.025. Epub 2008 Feb 12.

28.

Nitric oxide protects mast cells from activation-induced cell death: the role of the phosphatidylinositol-3 kinase-Akt-endothelial nitric oxide synthase pathway.

Inoue T, Suzuki Y, Yoshimaru T, Ra C.

J Leukoc Biol. 2008 May;83(5):1218-29. doi: 10.1189/jlb.1007667. Epub 2008 Feb 19.

PMID:
18285401
29.
30.

Reactive oxygen species produced up- or downstream of calcium influx regulate proinflammatory mediator release from mast cells: role of NADPH oxidase and mitochondria.

Inoue T, Suzuki Y, Yoshimaru T, Ra C.

Biochim Biophys Acta. 2008 May;1783(5):789-802. doi: 10.1016/j.bbamcr.2007.12.004. Epub 2007 Dec 15.

31.

Silver activates mast cells through reactive oxygen species production and a thiol-sensitive store-independent Ca2+ influx.

Yoshimaru T, Suzuki Y, Inoue T, Niide O, Ra C.

Free Radic Biol Med. 2006 Jun 1;40(11):1949-59. Epub 2006 Feb 14.

PMID:
16716896
32.

Mitochondrial Ca2+ flux is a critical determinant of the Ca2+ dependence of mast cell degranulation.

Suzuki Y, Yoshimaru T, Inoue T, Ra C.

J Leukoc Biol. 2006 Mar;79(3):508-18. Epub 2005 Dec 19.

PMID:
16365155
33.

Fungal metabolite gliotoxin blocks mast cell activation by a calcium- and superoxide-dependent mechanism: implications for immunosuppressive activities.

Niide O, Suzuki Y, Yoshimaru T, Inoue T, Takayama T, Ra C.

Clin Immunol. 2006 Jan;118(1):108-16. Epub 2005 Oct 6.

PMID:
16213796
34.

Role of oxidants in mast cell activation.

Suzuki Y, Yoshimaru T, Inoue T, Niide O, Ra C.

Chem Immunol Allergy. 2005;87:32-42. Review.

PMID:
16107761
35.

Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE.

Nunomura S, Gon Y, Yoshimaru T, Suzuki Y, Nishimoto H, Kawakami T, Ra C.

Int Immunol. 2005 Jun;17(6):685-94. Epub 2005 Jun 8.

PMID:
15944196
36.

Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner.

Suda T, Suzuki Y, Matsui T, Inoue T, Niide O, Yoshimaru T, Suzuki H, Ra C, Ochiai T.

Br J Dermatol. 2005 May;152(5):887-95.

PMID:
15888142
37.

Fc epsilon RI signaling of mast cells activates intracellular production of hydrogen peroxide: role in the regulation of calcium signals.

Suzuki Y, Yoshimaru T, Matsui T, Inoue T, Niide O, Nunomura S, Ra C.

J Immunol. 2003 Dec 1;171(11):6119-27.

39.

Blockade of superoxide generation prevents high-affinity immunoglobulin E receptor-mediated release of allergic mediators by rat mast cell line and human basophils.

Yoshimaru T, Suzuki Y, Matsui T, Yamashita K, Ochiai T, Yamaki M, Shimizu K.

Clin Exp Allergy. 2002 Apr;32(4):612-8.

PMID:
11972610
40.

Exposure of RBL-2H3 mast cells to Ag(+) induces cell degranulation and mediator release.

Suzuki Y, Yoshimaru T, Yamashita K, Matsui T, Yamaki M, Shimizu K.

Biochem Biophys Res Commun. 2001 May 11;283(3):707-14.

PMID:
11341783
41.

Diphenyleneiodonium prevents reactive oxygen species generation, tyrosine phosphorylation, and histamine release in RBL-2H3 mast cells.

Matsui T, Suzuki Y, Yamashita K, Yoshimaru T, Suzuki-Karasaki M, Hayakawa S, Yamaki M, Shimizu K.

Biochem Biophys Res Commun. 2000 Sep 24;276(2):742-8.

PMID:
11027541
42.

Epigallocatechin gallate inhibits histamine release from rat basophilic leukemia (RBL-2H3) cells: role of tyrosine phosphorylation pathway.

Yamashita K, Suzuki Y, Matsui T, Yoshimaru T, Yamaki M, Suzuki-Karasaki M, Hayakawa S, Shimizu K.

Biochem Biophys Res Commun. 2000 Aug 11;274(3):603-8. Erratum in: Biochem Biophys Res Commun 2000 Sep 16;276(1):391.

PMID:
10924324
43.

Preparation and characteristics of rumen-bypass microcapsules for improvement of productivity in ruminants.

Yoshimaru T, Shibata M, Fukugomori T, Matsumoto K.

J Agric Food Chem. 1999 Feb;47(2):554-7.

PMID:
10563932

Supplemental Content

Loading ...
Support Center